Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Daclizumab (anti-CD25) in multiple sclerosis.
Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia.
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats.
Pregnancy outcomes in female patients and partners of male patients in the teriflunomide clinical development program.
Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis.
Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects.
Identification of the LDL Receptor-Related Protein-1 Interactome in Central Nervous System myelin suggests a role in the clearance of necrotic cell debris.
Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.
Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis.
Fingolimod modulates microglial activation to augment markers of remyelination.
Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients.
Amiloride HCl
The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.
Demyelination affects temporal aspects of perception: An optic neuritis study.
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally.
SIRT1 deacetylates RORγt and enhances Th17 cell generation.
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases.
White matter astrocytes in health and disease.
Biogen Idec announces positive top-line results from Phase 3 study of peginterferon beta-1a in multiple sclerosis
Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis.
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
Shorter washout reduces MS relapse switching off natalizumab
Laquinimod
Pages
« first
‹ previous
…
93
94
95
96
97
98
99
100
101
…
next ›
last »